These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

72 related articles for article (PubMed ID: 16998974)

  • 1. The structure of an antibody molecule.
    Cancer J Sci Am; 1995; 1(1):83. PubMed ID: 16998974
    [No Abstract]   [Full Text] [Related]  

  • 2. Model building of antibody combining sites.
    Bajorath J; Novotny J
    Ther Immunol; 1995 Apr; 2(2):95-103. PubMed ID: 8729880
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Shapes of antibody binding sites: qualitative and quantitative analyses based on a geomorphic classification scheme.
    Lee M; Lloyd P; Zhang X; Schallhorn JM; Sugimoto K; Leach AG; Sapiro G; Houk KN
    J Org Chem; 2006 Jul; 71(14):5082-92. PubMed ID: 16808494
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Two and three-dimensional pattern recognition of organized surfaces by specific antibodies.
    Addadi L; Rubin N; Scheffer L; Ziblat R
    Acc Chem Res; 2008 Feb; 41(2):254-64. PubMed ID: 18217721
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Antibody therapeutics, antibody engineering, and the merits of protein stability.
    Demarest SJ; Glaser SM
    Curr Opin Drug Discov Devel; 2008 Sep; 11(5):675-87. PubMed ID: 18729019
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Antibody modelling. Tackling a loopy problem.
    Thornton JM
    Nature; 1990 Feb; 343(6257):411-2. PubMed ID: 2300188
    [No Abstract]   [Full Text] [Related]  

  • 7. Energy-based analysis and prediction of the orientation between light- and heavy-chain antibody variable domains.
    Narayanan A; Sellers BD; Jacobson MP
    J Mol Biol; 2009 May; 388(5):941-53. PubMed ID: 19324053
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Solution structure and neutralizing antibody binding studies of domain III of the dengue-2 virus envelope protein.
    Huang KC; Lee MC; Wu CW; Huang KJ; Lei HY; Cheng JW
    Proteins; 2008 Feb; 70(3):1116-9. PubMed ID: 18004779
    [No Abstract]   [Full Text] [Related]  

  • 9. A dynamical study of antibody-antigen encounter reactions.
    Bongini L; Fanelli D; Piazza F; De Los Rios P; Sanner M; Skoglund U
    Phys Biol; 2007 Oct; 4(3):172-80. PubMed ID: 17928656
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Engineering antibodies for stability and efficient folding.
    Honegger A
    Handb Exp Pharmacol; 2008; (181):47-68. PubMed ID: 18071941
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Molten globules move into action.
    Regan L
    Proc Natl Acad Sci U S A; 2003 Apr; 100(7):3553-4. PubMed ID: 12657734
    [No Abstract]   [Full Text] [Related]  

  • 12. Computational prediction of antibody binding sites on tetracycline antibiotics: electrostatic potentials and average local ionization energies on molecular surfaces.
    Kulshrestha P; Sukumar N; Murray JS; Giese RF; Wood TD
    J Phys Chem A; 2009 Jan; 113(4):756-66. PubMed ID: 19159333
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Human IgG1 Cgamma1 domain is crucial for the bioactivity of the engineered anti-CD20 antibodies.
    Geng S; Feng J; Li Y; Kang X; Sun Y; Gu X; Huang Y; Chang H; Shen BF
    Cell Mol Immunol; 2007 Apr; 4(2):121-5. PubMed ID: 17484806
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The intrinsic contributions of tyrosine, serine, glycine and arginine to the affinity and specificity of antibodies.
    Birtalan S; Zhang Y; Fellouse FA; Shao L; Schaefer G; Sidhu SS
    J Mol Biol; 2008 Apr; 377(5):1518-28. PubMed ID: 18336836
    [TBL] [Abstract][Full Text] [Related]  

  • 15. An antibody loop replacement design feasibility study and a loop-swapped dimer structure.
    Clark LA; Boriack-Sjodin PA; Day E; Eldredge J; Fitch C; Jarpe M; Miller S; Li Y; Simon K; van Vlijmen HW
    Protein Eng Des Sel; 2009 Feb; 22(2):93-101. PubMed ID: 19074157
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Neutralization of animal virus infectivity by antibody.
    Reading SA; Dimmock NJ
    Arch Virol; 2007; 152(6):1047-59. PubMed ID: 17516034
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Structure of the recombinant antibody Fab fragment f3p4.
    Frey D; Huber T; Plückthun A; Grütter MG
    Acta Crystallogr D Biol Crystallogr; 2008 Jun; 64(Pt 6):636-43. PubMed ID: 18560151
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Direct in vivo intracellular selection of conformation-sensitive antibody domains targeting Alzheimer's amyloid-beta oligomers.
    Meli G; Visintin M; Cannistraci I; Cattaneo A
    J Mol Biol; 2009 Apr; 387(3):584-606. PubMed ID: 19361429
    [TBL] [Abstract][Full Text] [Related]  

  • 19. In silico analysis of antibody-carbohydrate interactions and its application to xenoreactive antibodies.
    Agostino M; Sandrin MS; Thompson PE; Yuriev E; Ramsland PA
    Mol Immunol; 2009 Dec; 47(2-3):233-46. PubMed ID: 19828202
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Structure determinations of human and chimaeric antibodies by solution scattering and constrained molecular modelling.
    Perkins SJ; Bonner A
    Biochem Soc Trans; 2008 Feb; 36(Pt 1):37-42. PubMed ID: 18208381
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.